Drug details:
Molecular formula: C₂₁H₂₆NO₁₀P

Standard name: [3,4,5-trihydroxy-6-[2-methyl-4-[3-(methylcarbamoyl)phenyl]phenoxy]oxan-2-yl]methyl dihydrogen phosphate

Curated SMILES: CNC(=O)C1=CC(C2=CC=C(OC3OC(COP(=O)(O)O)C(O)C(O)C3O)C(C)=C2)=CC=C1

Evidence for compound's anti-virulence activity:

Escherichia
Related VF: Type 1 fimbriae
Target: FimH
Drug effect: Bound to the FimH lectin domain to interfere with bacterial adhesion, invasion and biofilm formation.
Max phase: Preclinical (in vivo)
Publication:
Mydock-McGrane L, et al., 2016. Antivirulence C-Mannosides as Antibiotic-Sparing, Oral Therapeutics for Urinary Tract Infections. J Med Chem 59(20):9390-9408.